In summary, LXRβ can inhibit Aβ production and enhance Aβ degradation, thereby reducing brain Aβ generation, increasing the expression of autophagy-related proteins, reducing the expression of Ras/Raf/Erkl/2 signaling pathway proteins, and eventually improving autism symptoms. Here, NR1H2 is linked to autism.